throbber
Dextran I for injection
`
`EUROPEAN PHARMACOPOEIA 5.0
`
`DEFINITION
`Dexpanthenol contains not less than 98.0 per cent and
`not more than the equivalent of 101.0 per cent of (2R)-2,
`4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide,
`calculated with reference to the anhydrous substance.
`
`CHARACTERS
`A colourless or slightly yellowish, viscous hygroscopic liquid,
`or a white or almost white, crystalline powder, very soluble
`in water, freely soluble in ethanol (96 per cent).
`
`IDENTIFICATION
`First identification: A, B.
`Second identification : A, C, D.
`A. It complies with the test for specific optical rotation (see
`Tests).
`B. Examine by infrared absorption spectrophotometry
`(2.2.24), comparing with the spectrum obtained with
`dexpanthenol CRS. Examine the substances using
`discs prepared as follows : dissolve the substance to be
`examined and the reference substance separately in
`1.0 ml of anhydrous ethanol R to obtain a concentration
`of 5 mg/ml. Place dropwise 0.5 ml of this solution on a
`disc of potassium bromide R. Dry the disc at 100-105 °C
`for 15 min.
`C. Examine the chromatograms obtained in the test for
`3-aminopropanol. The principal spot in the chromatogram
`obtained with test solution (b) is similar in position,
`colour and size to the principal spot in the chromatogram
`obtained with reference solution (a).
`D. To 1 ml of solution S (see Tests) add 1 ml of dilute sodium
`hydroxide solution Rand 0.1 ml of copper sulphate
`solution R. A blue colour develops.
`
`TESTS
`Solution S. Dissolve 2.500 g in carbon dioxide-free water R
`and dilute to 50.0 ml with the same solvent.
`Appearance of solution. Solution Sis clear (2.2.1) and not
`more intensely coloured than reference solution 8 6 (2.2.2,
`Method II).
`pH (2.2.3). The pH of solution S is not greater than 10.5.
`Specific optical rotation (2.2. 7). The specific optical rotation
`is + 29.0 to + 32.0, determined on solution S and calculated
`with reference to the anhydrous substance.
`3-Aminopropanol. Examine by thin-layer chromatography
`(2.2.27), using silica gel GR as the coating substance.
`Test solution (a). Dissolve 0.25 g of the substance to be
`examined in anhydrous ethanol R and dilute to 5 ml with
`the same solvent.
`Test solution (b). Dilute 1 ml of test solution (a) to 10 ml
`with anhydrous ethanol R.
`Reference solution (a). Dissolve the contents of a vial of
`dexpanthenol CRS in 1.0 ml of anhydrous ethanol R to
`obtain a concentration of 5 mg/ml.
`Reference solution (b). Dissolve 25 mg of 3-aminopropanol R
`in anhydrous ethanol Rand dilute to 100 ml with the same
`solvent.
`Apply separately to the plate 10 µl of each solution. Develop
`over a path of 15 cm using a mixture of 20 volumes of
`concentrated ammonia R, 25 volumes of methanol Rand
`55 volumes of butanol R. Allow the plate to dry in air,
`spray with a 100 g/1 solution of trichloroacetic acid R in
`methanol Rand heat at 150 °C for 10 min. Spray with a 1 g/)
`solution of ninhydrin R in methanol Rand heat at 120 °C
`until a colour appears. Any spot due to 3-aminopropanol
`
`in the chromatogram obtained with test solution (a) is not
`more intense than the spot in the chromatogram obtained
`with reference solution (b) (0.5 per cent).
`Heavy metals (2.4.8) . 12 ml of solution S complies with limit
`test A for heavy metals (20 ppm). Prepare the reference
`solution using lead standard solution (1 ppm Pb) R.
`Water (2.5.12). Not more than 1.0 per cent, determined on
`l.OOO g.
`Sulphated ash (2.4.14). Not more than 0.1 per cent,
`determined on 1.0 g.
`
`ASSAY
`To 0.400 g add 50.0 ml of 0.1 M perchloric acid. Boil under
`a reflux condenser for 5 h protected from humidity. Allow
`to cool. Add 50 ml of dioxan R by rinsing the condenser,
`protected from humidity. Add 0.2 ml of naphtholbenzein
`solution Rand titrate with 0.1 M potassium hydrogen
`phthalate until the colour changes from green to yellow.
`Carry out a blank titration.
`1 ml of 0.1 M perchloric acid is equivalent to 20.53 mg
`of C9H19N04•
`
`STORAGE
`In an airtight container.
`
`Ol/2005:1506
`
`DEXTRAN 1 FOR INJECTION
`
`Dextranum 1 ad iniectabile
`DEFINITION
`Dextran 1 for injection is a low molecular weight fraction of
`dextran, consisting of a mixture of isomaltooligosaccharides.
`The average relative molecular mass is about 1000.
`
`PRODUCTION
`It is obtained by hydrolysis and fractionation of dextrans
`produced by fermentation of sucrose using Leuconostoc
`mesenteroides strain NRRL 8-512 = CIP 78.59 or
`substrains thereof (for example L. mesenteroides B-512
`F = NCTC 10817).
`It is prepared in conditions designed to minimise the risk
`of microbial contamination.
`
`CHARACTERS
`A white or almost white powder, hygroscopic, very soluble in
`water, very slightly soluble in alcohol.
`
`IDENTIFICATION
`A. Dissolve 3.000 g in water R, heat on a water-bath and
`dilute to 100.0 ml with the same solvent. The specific
`optical rotation (2.2.7) is+ 148 to+ 164, calculated with
`reference to the dried substance. Dry an aliquot of the
`solution first on a water-bath and then to constant weight
`in vacuo at 70 °C. Calculate the dextran content after
`correction for the content of sodium chloride.
`B. Examine by infrared absorption spectrophotometry
`(2.2.24), comparing with the spectrum obtained with
`dextran 1 CRS. Prepare the discs as follows: to 1-2 mg
`add one or a few drops of water R; grind in an agate
`mortar for 1-2 min; add about 300 mg of potassium
`bromide Rand mix to a slurry (do not grind); dry in vacuo
`at 40 °C for 15 min, crush the residue (if it is not dry,
`dry for another 15 min). Prepare a disc using potassium
`bromide R. Run the infrared spectrum with a blank disc
`using potassium bromide R in the reference beam.
`
`1408
`
`See the information section on general monographs (cover pages)
`
`PGR2020-00009
`Pharmacosmos A/S v. American Regent, Inc.
`Petitioner Ex. 1038 - Page 1
`
`

`

`EUROPEAN PHARMACOPOEIA 5.0
`
`Dextran 40 for injection
`
`C. It complies with the test for molecular-mass distribution
`(see Tests).
`
`TESTS
`Solution S. Dissolve 7.5 g in carbon dioxide-free water R,
`heat on a water-bath and dilute to 50 ml with the same
`solvent.
`Absorbance (2.2.25). Measure the absorbance of solution S
`at 375 nm. The absorbance is not more than 0.12.
`Acidity or alkalinity. To 10 ml of solution S add 0.1 ml of
`phenolphthalein solution R. The solution is colourless.
`Add 0.2 ml of 0.01 M sodium hydroxide. The solution is
`pink. Add 0.4 ml of 0.01 M hydrochloric acid. The solution
`is colourless. Add 0.1 ml of methyl red solution R. The
`solution is red or orange.
`Nitrogen-containing substances. Carry out the
`determination of nitrogen by sulphuric acid digestion (2.5.9),
`using 0.200 g and heating for 2 h. Collect the distillate in a
`mixture of 0.5 ml of bromocresol green solution R, 0.5 ml
`of methyl red solution Rand 20 ml of water R. Titrate with
`0.01 M hydrochloric acid. Not more than 0.15 ml of 0.01 M
`hydrochloric acid is required to change the colour of the
`indicator (llO ppm N).
`Sodium chloride. Not more than 1.5 per cent. Accurately
`weigh 3-5 g and dissolve in 100 ml of water R. Add 0.3 ml
`of potassium chromate solution Rand titrate with 0.1 M
`silver nitrate until the yellowish-white colour changes to
`reddish-brown.
`1 ml of 0.1 M silver nitrate is equivalent to 5.844 mg of NaCl.
`Molecular-mass distribution. The average molecular mass
`(MJ is 850 to ll50. The fraction with less than 3 units of
`glucose is less than 15 per cent, the fraction with more than
`9 units of glucose is less than 20 per cent.
`
`Examine by size-exclusion chromatography (2.2.30).
`Test solution. Dissolve 6.0-6.5 mg of the substance to be
`examined in 1.0 ml of the mobile phase.
`Reference solution (a). Dissolve 6.0-6.5 mg of dextran 1 CRS
`in 1.0 ml of the mobile phase.
`Reference solution (b). Dissolve the content of an ampoule
`of isomaltooligosaccharide CRS in 1 ml of the mobile
`phase, and mix. This corresponds to approximately 45 µg
`of isomaltotriose (3 glucose units), approximately 45 µg of
`isomaltononaose (9 glucose units), and approximately 60 µg
`of sodium chloride per 100 µI.
`
`The chromatographic procedure may be carried out using:
`
`2 columns, 30 cm long and 10 mm in internal diameter,
`in series, prepacked with a packing material of dextran
`covalently bound to highly cross-linked porous agarose
`beads, allowing resolution of oligosaccharides in
`the molecular mass range of 180 to 3000, kept at a
`temperature of 20-25 °C,
`
`as mobile phase at a flow rate of 0.07-0.08 ml/min
`maintained constant to ± 1 per cent, a 2.92 g/1 solution
`of sodium chloride R,
`as detector a differential refractometer.
`
`Inject 100 µl of reference solution (b) and record
`the chromatogram for definition of the positions of
`isomaltotriose, isomaltononaose and sodium chloride. Inject
`100 µl of the test solution and 100 µl of reference solution (a)
`and record the chromatograms. Determine the peak areas.
`Disregard any peak due to sodium chloride.
`
`Calculate the average relative molecular mass Mw and the
`amount of the fraction with less than 3 and more than 9
`glucose units, of dextran 1 CRS and of the substance to be
`examined. The test is not valid unless the values obtained
`for dextran 1 CRS are within the values stated on the label.
`Mw = LWi X m ;
`
`Mw
`average molecular mass of the dextran,
`m,
`molecular mass of oligosaccharide i,
`w,
`weight proportion of oligosaccharide i.
`Use the following molecular mass values for the calculation:
`
`m,
`180
`342
`504
`666
`828
`990
`ll52
`1314
`1476
`1638
`1800
`1962
`2124
`2286
`2448
`2610
`2772
`2934
`3096
`
`Oligosaccharide i
`glucose
`isomaltose
`isomaltotriose
`isomaltotetraose
`isomaltopentaose
`isomaltohexaose
`isomaltoheptaose
`isomaltooctaose
`isomaltononaose
`isomaltodecaose
`isomaltoundecaose
`isomaltododecaose
`isomaltotridecaose
`isomaltotetradecaose
`isomaltopentadecaose
`isomaltohexadecaose
`isomaltoheptadecaose
`isomaltooctadecaose
`isomaltononadecaose
`Heavy metals (2.4.8). Dilute 20 ml of solution S to 30 ml
`with water R. 12 ml of this solution complies with limit
`test A (10 ppm). Prepare the reference solution using lead
`standard solution (1 ppm Pb) R.
`Loss on drying (2.2.32). Not more than 5.0 per cent,
`determined on 5.000 g by drying in an oven at 100-105 °C
`for 5 h.
`Bacterial endotoxins (2.6.14) : less than 25 IU/ g.
`Microbial contamination. Total viable aerobic count (2. 6.12)
`not more than 102 micro-organisms per gram, determined
`by plate-count. It complies with the test for Escherichia
`coli (2.6.13).
`
`01/2005:0999
`
`DEXTRAN 40 FOR INJECTION
`
`Dextranum 40 ad iniectabile
`DEFINITION
`Dextran 40 for injection is a mixture of polysaccharides,
`principally of the a-1,6-glucan type.
`The average relative molecular mass is about 40 000.
`
`General Notices (1) apply to all monographs and other texts
`
`1409
`
`PGR2020-00009
`Pharmacosmos A/S v. American Regent, Inc.
`Petitioner Ex. 1038 - Page 2
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket